Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Change in Cash: 2017-2025

Historic Change in Cash for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to -$1.1 million.

  • Puma Biotechnology's Change in Cash fell 1097.37% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.7 million, marking a year-over-year increase of 8.64%. This contributed to the annual value of -$15.4 million for FY2024, which is 294.90% down from last year.
  • Latest data reveals that Puma Biotechnology reported Change in Cash of -$1.1 million as of Q3 2025, which was up 86.41% from -$8.4 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Change in Cash registered a high of $25.2 million during Q3 2022, and its lowest value of -$25.9 million during Q3 2021.
  • Moreover, its 3-year median value for Change in Cash was -$1.4 million (2023), whereas its average is -$2.1 million.
  • Its Change in Cash has fluctuated over the past 5 years, first slumped by 3,078.04% in 2021, then surged by 229.90% in 2023.
  • Quarterly analysis of 5 years shows Puma Biotechnology's Change in Cash stood at -$816,000 in 2021, then tumbled by 115.56% to -$1.8 million in 2022, then surged by 229.90% to $2.3 million in 2023, then declined by 14.40% to $2.0 million in 2024, then tumbled by 1,097.37% to -$1.1 million in 2025.
  • Its Change in Cash was -$1.1 million in Q3 2025, compared to -$8.4 million in Q2 2025 and -$6.2 million in Q1 2025.